Swiss Lonza Group Ltd. Eyes Stake in India Drug Firm, Aptuit Laurus in Deal Valued at $77 Million to $99 Million

Reuters -- Swiss drugs industry supplier Lonza (LONN.VX) is in talks to buy over 51 percent stake in India's Aptuit Laurus in a deal valued at $77 million to $99 million, the Business Standard reported on Wednesday.